Institut Claudius Regaud: Breast Neoplasms trials
The registry lists 27 Breast Neoplasms studies with Institut Claudius Regaud as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 3Phase 4 5No phase 17(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2Not yet recruitingNCT07558343Not applicable
- Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast CancersRecruitingNCT07233928Not applicable
- Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.RecruitingNCT07195344Phase 4
- Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate CancerRecruitingNCT06904625Not applicable
- Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.RecruitingNCT05378204Not applicable
- Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast CancerRecruitingNCT04740697Not applicable
- Prospective and Retrospective Breast Cancer DatabaseRecruitingNCT02884284
- Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast CancerCompletedNCT06408038Not applicable
- Male breAsT cAncer preDisposition FactorCompletedNCT06219187
- Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.CompletedNCT04818125Not applicable
- Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BCCompletedNCT04368468
- E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.CompletedNCT04228432Not applicable
- Chronic Pain and Minor Breast Cancer SurgeryCompletedNCT03912948
- The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.TerminatedNCT03619044Not applicable
- Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast CancerCompletedNCT03289286Not applicable
- Study of Trans-tissular Migration of Macrophages Associated to Human Breast CancerStatus unknownNCT02876497Not applicable
- From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast CancersStatus unknownNCT02863900Not applicable
- Therapeutic Nipple Sparing Mastectomy.CompletedNCT02311959Phase 3
- Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mmCompletedNCT02266420Not applicable
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4
- Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall SurvivalCompletedNCT01574170Phase 4
- Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotCompletedNCT01553903Phase 4
- Pharmacology of Adjuvant Hormonotherapy in Breast CancerCompletedNCT01127295Phase 4
- Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment SequellaTerminatedNCT01035268Phase 3
- Exemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantCompletedNCT00919399Phase 2
- Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.CompletedNCT00268125Phase 3
- Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerTerminatedNCT00210028Phase 2